BPTF and breast cancer: Furthermore, inhibition of heparanase expression in breast cancer cells via knockdown of the bromodomain PHD finger transcription factor (BPTF), a known activator of heparanase expression, enhanced antitumor NK cell-mediated cytolytic activity in the TME (Mayes et al., 2017; Wang et al., 2023).